Skip to content
Sunday, May 18, 2025
Latest:
  • GammaDelta Therapeutics Announces Publication of New Data in Nature Immunology Describing the Independent Immune Function of Gamma Delta (gd) T Cell Receptors
  • Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference
  • Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference
  • Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference
  • Carrick Therapeutics In-Licenses Targeted Ovarian Cancer Treatment From BTG and Appoints George Golumbeski as Chairman

Pure Luxury Living

Made in Italy

  • Home
  • Arredamento
  • Casa
  • Giardino
  • Design
  • Contatti
  • English
    • Italiano
    • Español
    • English
    • Français
    • Deutsch
    • Nederlands
blog

GammaDelta Therapeutics Announces Publication of New Data in Nature Immunology Describing the Independent Immune Function of Gamma Delta (gd) T Cell Receptors

November 13, 2018 belAdmin 1216 Views

Findings support development of γδ T cells for gastrointestinal diseases  GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies

Read More
blog

Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference

October 26, 2018 belAdmin 996 Views

Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run

Read More
blog

Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference

October 26, 2018 belAdmin 901 Views

Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run

Read More
blog

Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference

October 26, 2018 belAdmin 829 Views

Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run

Read More
blog

Carrick Therapeutics In-Licenses Targeted Ovarian Cancer Treatment From BTG and Appoints George Golumbeski as Chairman

October 11, 2018 belAdmin 803 Views

Exclusive worldwide licence deal adding to Carrick”s rapid pipeline expansion Preparations for pivotal studies underway Dr. George Golumbeski appointed as

Read More
blog

Bitumen Market to Witness Enhanced Application Into Adhesives, Waterproofing, Insulation and Roadways till 2024 | Million Insights

October 3, 2018 belAdmin 811 Views

The global Bitumen Market is estimated to develop at a substantial CAGR for the duration of the prediction due to

Read More
blog

CRB opens second office in Europe, hires Bernd Müller

October 1, 2018 belAdmin 843 Views

‘The opening of operations for CRB in Germany strategically aligns with our clients” growth in the region over the last

Read More
blog

Regen BioPharma, Inc. Reports Activation of Immune Cells by Its NR2F6 Small Molecule Inhibitors

September 21, 2018 belAdmin 1081 Views

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), reports its researchers have identified a series of small molecule drugs that

Read More
blog

Avison Young Acquires Market-Leading U.K. Firm Wilkinson Williams LLP, Opens New Office in London’s West End; 16 Members Join

August 1, 2018 belAdmin 1075 Views

Purchase expands Avison Young”s U.K. footprint and adds eight Principals  Mark E. Rose, Chair and CEO of Avison Young, the world”s

Read More
blog

4D Presents at IHMC 2018

June 27, 2018 belAdmin 799 Views

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company”s Chief

Read More
  • ← Previous
blog

GammaDelta Therapeutics Announces Publication of New Data in Nature Immunology Describing the Independent Immune Function of Gamma Delta (gd) T Cell Receptors

November 13, 2018 belAdmin
blog

Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference

October 26, 2018 belAdmin
blog

Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference

October 26, 2018 belAdmin
blog

Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference

October 26, 2018 belAdmin
blog

Carrick Therapeutics In-Licenses Targeted Ovarian Cancer Treatment From BTG and Appoints George Golumbeski as Chairman

October 11, 2018 belAdmin
blog

Bitumen Market to Witness Enhanced Application Into Adhesives, Waterproofing, Insulation and Roadways till 2024 | Million Insights

October 3, 2018 belAdmin
CRB opens second office in Europe, hires Bernd Müller
blog

CRB opens second office in Europe, hires Bernd Müller

October 1, 2018 belAdmin
blog

Regen BioPharma, Inc. Reports Activation of Immune Cells by Its NR2F6 Small Molecule Inhibitors

September 21, 2018 belAdmin

Copyright © 2025 Pure Luxury Living. All rights reserved. PI: IT13326330969 - Privacy Policy - Cookie Policy